Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon

Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, et al. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med. 2008;359(23):2429-2441.

Publication Type:

Journal Article

Authors:

A M Di Bisceglie; Shiffman, M.L.; G.T. Everson; Lindsay, K.L.; Everhart, J.E.; Wright, E.C.; Lee, W.M.; Lok, A.S.; Bonkovsky, H.L.; Morgan, T.R.; Ghany, M.G.; Morishima, C.; Snow, K.K.; Dienstag, J.L.; HALT-C trial investigators

Source:

N Engl J Med, Volume 359, Issue 23, p.2429-2441 (2008)

Keywords:

administration & dosage, adverse effects, Alanine, Alanine Transaminase, Antiviral Agents, Biopsy, blood, Carcinoma, Carcinoma,Hepatocellular, Death, Disease, Disease Progression, Drug Administration Schedule, drug therapy, etiology, Female, Fibrosis, Gastroenterology, genetics, Hepacivirus, hepatitis, Hepatitis C, hepatitis C virus, Hepatitis C,Chronic, Humans, interferon, Interferon Alfa-2a, Interferon-alpha, Internal Medicine, isolation & purification, Kaplan-Meier Estimate, Liver, Liver Cirrhosis, Liver Failure, Liver Neoplasms, Male, Medicine, methods, Middle Aged, Mortality, Multicenter Studies, pathology, Patients, peginterferon, Proportional Hazards Models, Proteins, Recombinant Proteins, Research, Research Support, Ribavirin, Rna, Rna,Viral, Serum, therapeutic use, therapy, treatment, Treatment Outcome, virology

Notes:

PMC2606037

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/19052125

Export Citation:
RIS Format
Top